Exact Sciences (EXAS) Update | Gorilla Trades
Exact Sciences (EXAS) recent earnings announcement confirmed that it is, in fact, on the right track. With its first-quarter earnings release on April 30th, 2019, EXAS reported that it had completed 334,000 Cologuard tests in the quarter, up 79% from a year ago. (The consensus estimate had called for far fewer tests.) The better-than-expected volume was…